Leading our mid-week Green Deals is Velotric’s Earth Day e-bike sale with up to $562 savings, like the Fold 1 Plus Folding ...

Avinox's new M2S motor complies with UK and EU legislation, but some are worried the high peak power could invite unwanted ...

Composition of Health Care Contact Days and Mortality Prediction Among Older Adult Clinical Trial Participants In this cross-sectional study, we used US Food and Drug Administration’s (FDA), European ...

Review Duration and Therapeutic Value of Cancer Drugs Granted Priority Versus Nonpriority Review in the United States, European Union, and Switzerland (2010-2024) Review Duration and Therapeutic Value ...

Praxis Precision Medicines' New Drug Application for relutrigine will receive priority review by the Food and Drug Administration. The clinical-stage biopharmaceutical company said Monday that the FDA ...

STOCKHOLM, SE / ACCESS Newswire / March 27, 2026 / Egetis Therapeutics (STO:EGTX) - Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm:EGTX), today announced that the U.S.

Reviewing the Southwest Rapid Rewards Priority Credit Card. Is the annual fee worth the benefits like travel credit, anniversary points, and upgraded boardings? Find out! The reason so many Americans ...

Since its introduction nine months ago, the FDA’s national priority voucher pilot program has attracted intrigue and fierce criticism while also yielding several rapid drug approvals. With all of this ...

AstraZeneca PLC (NYSE:AZN) is one of Goldman Sachs top healthcare stocks. On March 9, AstraZeneca PLC (NYSE:AZN) and Daiichi Sankyo secured Priority Review in the US for Enhertu, their candidate drug ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the most promising stocks under $20. On March 2, Takeda and Protagonist Therapeutics announced that the US FDA accepted the New Drug ...

Priovant Therapeutics, a company backed by Pfizer (PFE) and Roivant Sciences (ROIV), announced on Tuesday that the U.S. FDA has granted priority review for its marketing application targeted at its ...

Priority review follows NDA acceptance for a first-in-class hepcidin mimetic in PV, supported by breakthrough therapy, orphan drug, and fast track designations. Rusfertide targets iron regulation to ...